With congressional concurrence, the Congressional Research Service refuses to make its products directly available to the public. Some noteworthy new CRS reports obtained by Secrecy News include the following (all pdf).
“Presidential Advisers’ Testimony Before Congressional Committees: An Overview,” updated April 10, 2007.
“Information Operations, Electronic Warfare, and Cyberwar: Capabilities and Related Policy Issues,” updated March 20, 2007.
“Network Centric Operations: Background and Oversight Issues for Congress,” updated March 15, 2007.
“Statutes of Limitation in Federal Criminal Cases: An Overview,” updated April 9, 2007.
“Speechwriting in Perspective: A Brief Guide to Effective and Persuasive Communication,” April 12, 2007.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.